Neuropilin-1 (Nrp1) is a cell surface molecule originally identified for its role in neuronal development. Recently, Nrp1 has been implicated in several aspects of immune function including maintenance of the immune synapse and development of regulatory T (T reg ) cells. In this study, we provide evidence for a central role of Nrp1 in the regulation of CD4 T-cell immune responses in experimental autoimmune encephalitis (EAE). EAE serves as an animal model for the central nervous system (CNS) inflammatory disorder multiple sclerosis (MS). EAE is mediated primarily by CD4 + T cells that migrate to the CNS and mount an inflammatory attack against myelin components, resulting in CNS pathology. Using a tissue-specific deletion system, we observed that the lack of Nrp1 on CD4 + T cells results in increased EAE severity. These conditional knockout mice exhibit preferential T H -17 lineage commitment and decreased T reg -cell functionality. Conversely, CD4 + T cells expressing Nrp1 suppress effector T-cell proliferation and cytokine production both in vivo and in vitro independent of T reg cells. Nrp1-mediated suppression can be inhibited by TGF-β blockade but not by IL-10 blockade. These results suggest that Nrp1 is essential for proper maintenance of peripheral tolerance and its absence can result in unchecked autoreactive responses, leading to diseases like EAE and potentially MS.
Neuropilin-1 (Nrp1) is a cell surface molecule originally identified for its role in neuronal development. Recently, Nrp1 has been implicated in several aspects of immune function including maintenance of the immune synapse and development of regulatory T (T reg ) cells. In this study, we provide evidence for a central role of Nrp1 in the regulation of CD4 T-cell immune responses in experimental autoimmune encephalitis (EAE). EAE serves as an animal model for the central nervous system (CNS) inflammatory disorder multiple sclerosis (MS) . EAE is mediated primarily by CD4 + T cells that migrate to the CNS and mount an inflammatory attack against myelin components, resulting in CNS pathology. Using a tissue-specific deletion system, we observed that the lack of Nrp1 on CD4 + T cells results in increased EAE severity. These conditional knockout mice exhibit preferential T H -17 lineage commitment and decreased T reg -cell functionality. Conversely, CD4
+ T cells expressing Nrp1 suppress effector T-cell proliferation and cytokine production both in vivo and in vitro independent of T reg cells. Nrp1-mediated suppression can be inhibited by TGF-β blockade but not by IL-10 blockade. These results suggest that Nrp1 is essential for proper maintenance of peripheral tolerance and its absence can result in unchecked autoreactive responses, leading to diseases like EAE and potentially MS. M ultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterized by progressive demyelination of the brain and spinal cord (1) . MS patients develop paralysis because of immune-mediated axonal damage. MS is generally considered to be an autoimmune disease orchestrated by T H -1 and T H -17 lymphocytes, although various genetic and environmental factors also play a part in disease etiology (2, 3) . Evidence for the role of immune cells in MS pathogenesis is provided by studies using the mouse model experimental autoimmune encephalomyelitis (EAE). In EAE, myelin-specific CD4 + T lymphocytes migrate into the CNS and mediate neuronal demyelination and destruction similar to that seen in MS patients (4) , leading to loss of motor function and paralysis.
Comparisons between the immune system and the CNS began with the naming of dendritic cells (5) . For example, the term immunological synapse describes the junction formed between T cells and antigen-presenting cells (APCs), which resembles the synapse between neurons in both formation and architecture (6) . In the nervous system, chemorepulsive factors, such as semaphorins, are required for guiding the formation of neuronal synapses. Several reports have also suggested important roles for semaphorins in the immune system (7, 8) . Neuropilin-1 (Nrp1) is a type 1 transmembrane protein, originally identified for its role in the development of growing neurons, which can serve as a receptor for semaphorin-3A in combination with plexin molecules to regulate growth cone collapse (9) (10) (11) . In addition, Nrp1 is involved in the process of angiogenesis through interactions with vascular endothelial growth factor (VEGF) (12) . Nrp1 has been recently implicated to play a role in the immunological synapse (13) and has been reported to be constitutively expressed on murine CD4 + CD25 + regulatory T (T reg ) cells, suggesting a potential role for Nrp1 in the attenuation of autoreactive immune responses (14) .
We have shown that mice epicutaneously immunized (ECi) with myelin peptide before induction of EAE show a significant degree of protection compared with non-ECi mice (15) . Myelinspecific CD4 + T cells from these ECi mice are able to confer protection from EAE to naïve recipient mice upon adoptive transfer (15) . Through gene analysis, we observed that Nrp1 is highly expressed on CD4 + T suppressor cells from mice protected from EAE development by ECi with myelin antigen. We therefore examined the role of Nrp1 in the immune response in EAE, because we hypothesized that Nrp1 may have a protective function in EAE development.
Here, we show that overexpression of Nrp1 attenuates EAE progression and, conversely, the lack of Nrp1 results in disease aggravation. This increase in disease severity occurs in a CD4 + Tcell-dependent manner (that skews the balance of helper T cells away from regulatory subtypes toward inflammatory T H -17 subtypes). We demonstrate that the suppressive effect of CD4 + T cells from myelin antigen-ECi mice appears to be independent of Foxp3, because the lack of Nrp1 impairs immune suppression without altering Foxp3 expression. Because of the complex relationship among Foxp3, Nrp1, and T reg cells in general, CD4 +
Nrp1
+ cells, such as those studied in the ECi model, are hereafter referred to as simply "suppressor T cells" so as not to erroneously place them into a specific area of the current T reg cell paradigm. These results demonstrate a specific role for Nrp1 in CD4 + T-cell immune response.
Results
Nrp1 Expression Is Protective Against EAE. We have shown that mice with T-cell receptor transgenic for the peptide Ac1-11 of myelin basic protein, when epicutaneously immunized (ECi) with the same peptide, are protected from EAE (15) . Further, C57BL/6 mice ECi with myelin oligodendrocyte glycoprotein peptide (MOG 35-55 , referred to as MOG) are resistant to EAE pathogenesis (Fig. 1A) . CD4 + T cells from these mice can confer dominant suppression against EAE (ref. 15 and Fig. S1A ). To determine the basis of this protection, we performed microarray gene analysis to assess the gene expression profile of CD4 + T cells from MOG ECi mice compared with PBS control or unimmunized control mice. One of the most up-regulated genes in this study was Nrp1, exhibiting greater than fivefold induction in the MOG ECi mice compared with control mice. Because Nrp1 has been proposed to be a constitutive marker of T reg cells (14) , we compared Nrp1 mRNA expression in CD4 + T cells of both naïve and MOG ECi mice to naïve CD4 + CD25 + T cells. As expected, Nrp1 expression was substantially higher (≥7-fold) in naive CD4 S1C ). These results demonstrate higher expression of Nrp1 on MOG ECi CD4 + T "suppressor" cells compared with traditional T reg cells.
To determine whether the protection seen in MOG or Ac1-11 ECi mice could be explained solely by the up-regulation of Nrp1, we overexpressed Nrp1 in vivo and followed EAE progression. We first constructed a retroviral GFP vector containing mouse Nrp1 cDNA. We then isolated CD4 + T cells from naïve myelin basic protein (MBP)-T-cell receptor (TCR)-Transgenic (Tg) mice (MBP-TCR-Tg) (15) , activated them in vitro with Ac1-11 peptide of MBP, and transduced them with either the Nrp1 construct or an empty vector. Successfully transduced CD4 + T cells were then cotransferred with untransduced, Ac1-11 activated, MBP-TCRTg, CD4 + T cells into syngeneic recipient (B10.PL-TCRα −/− ) mice. Mice receiving T cells transduced with the Nrp1 expression vector exhibited significant resistance to EAE pathogenesis compared with those receiving the GFP null vector or the naïve CD4 + T cells alone ( Fig. 1B and Table S1 ). This result suggests that increased expression of Nrp1 alone is sufficient to recapitulate the EAE protection previously observed in mice ECi with myelin peptide.
Nrp1 Conditional Knockout Mice Exhibit Severe EAE. We next asked whether the lack of Nrp1 would result in increased susceptibility to EAE by using a T-cell specific Nrp1 knockout mouse (Nrp1 (Fig. S2) .
To determine whether the aggravated disease in Nrp1 factor RORγt, which is important for T H -17 differentiation (Fig.  S3) . Autoreactive Cells. CD4 + T cells could lead to increased EAE pathogenesis through reduced T reg cell function. The lack of Nrp1 might impair the ability of the immune system to suppress autoreactive cells, indirectly leading to increased autoinflammatory cell proliferation. Previous findings support this hypothesis because Nrp1 has been reported to be constitutively expressed on T reg cells (14) . Therefore, we asked whether immune suppression in Nrp1 flx/flx
CD4Cre
+ mice is altered, in addition to the predisposition toward inflammatory subtypes, as demonstrated earlier (Fig. 2) (Fig. 3A) . Interestingly, at all suppressor to responder cell ratios, CD4 + Nrp1 + T cells suppressed effector cell proliferation more efficiently than CD4 + CD25 + T cells (Fig. 3A) . 
Nrp1
+ T cells (Fig. 3A) . These results indicate that the corresponding Nrp1 flx/flx
CD4Cre
+ CD4 + T cells are impaired in their ability to curb immune proliferation. To determine whether this difference in suppression is significant in vivo and to more specifically define the role of Table S5) . From these observations, we conclude that Nrp1-expressing CD4 + T cells are capable of suppressing EAE inflammatory response independent of naturally occurring T reg cell involvement. We also conclude that naturally occurring T reg cells expressing Nrp1 are more efficient suppressors than T reg cells lacking Nrp-1 expression. These findings suggest that a major role of Nrp1 in the immune response is in regulating inflammatory responses by CD4 + effector T cells. CD4Cre + mice (Fig. S4) , we asked whether IL-10 is involved in Nrp1 suppression of target cell proliferation by neutralizing IL-10 in vitro (18) . CD4 + CD25 + T cells or CD4 + CD25 − Nrp1 + cells from WT mice were used as suppressors in the presence or absence of anti-IL-10 ( Fig. 4A) . Interestingly, anti-IL-10 abrogated WT CD4 + CD25
+ cell suppression of target cell proliferation (Fig. 4A) , but had little effect on WT CD4
+ cell suppression (Fig. 4A) . These results suggest that Nrp1 suppressor function does not depend on IL-10. We next asked whether TGF-β is involved in Nrp1-mediated suppression by evaluating it in the presence or absence of anti-TGF-β (18) . As shown in Fig. 4B , anti-TGF-β significantly inhibited WT CD4 + CD25 − Nrp1 + T-cell suppression of effector cell proliferation but had little effect on WT CD4 + CD25 + T-cell suppression. These data strongly indicate that Nrp1 suppression of CD4 + T-cell effector function depends on TGF-β.
Discussion
The goal of this study was to elucidate the role of Nrp1 in EAE pathogenesis. As shown in Fig. 1A , initial ECi with MOG before induction of EAE results in complete protection against disease progression. Through global gene expression analysis, we found that Nrp1 is one of the most highly expressed genes in this protective response. These results, along with previous data suggesting a role for Nrp1 in immune suppression, led us to hypothesize that Nrp1 is important for preventing autoinflammatory conditions such as EAE. Our hypothesis is supported by data showing that overexpression of Nrp1 is sufficient to protect mice from EAE pathogenesis as well as the converse finding that the lack of Nrp1 results in increased disease severity. Protection and disease aggravation are CD4 + T-cell-dependent, because these disease states can be recapitulated in T-cell-deficient recipients when exogenous T cells overexpressing or lacking Nrp1, respectively, are transferred. Furthermore, our data strongly demonstrate that Nrp1 plays a critical role in regulating the expansion and cytokine production of T H -17 cells both in vitro and in vivo.
Because of the discovery of the T H -17 lineage of CD4 + T cells, many autoimmune disorders previously described as T H -1-mediated, including MS and EAE, have been reattributed to T H -17 cells (19) . Accordingly, we demonstrate that Nrp1-deficient CD4 + T cells are poised to differentiate into the T H -17 lineage. Furthermore, blockade of T H -17 cell development with an anti- 
CD4Cre
+ mice (n ≥ 3) were isolated, stained for CD4 and Foxp3, and analyzed by FACS. Results are representative of three experiments.
T H -17 antibody regimen suppressed EAE in Nrp1 flx/flx CD4Cre + mice. These results further support our hypothesis that one mechanism by which Nrp1 controls autoreactivity is by regulating T H -17 cell expansion and cytokine production.
As of yet, no signaling pathway has been attributed specifically to Nrp1. Although Nrp1 comprises one chain of the semaphorin-3A receptor, the second chain, plexin-A, is responsible for initiating cell signaling as a result of receptor ligation (20) . Studies show that dendritic cells produce large amounts of semaphorin-3A (8) . Moreover, the side chain of plexin-A is expressed on CD4 + T cells and plexin-A4 −/− mice exhibit increased EAE pathogenicity (21) . Together with our findings, these results suggest that secretion of semaphorin-3A by DCs may represent a negative feedback loop to reduce the duration of T-cell-APC interaction and, consequently, reduce the expression of inflammatory molecules such as IL-17. In neuronal cells, semaphorin-3 signaling through the Nrp1:plexin-A complex acts through a rho/rac-dependent pathway leading to actin depolymerization and growth cone collapse (10) . Similarly, Nrp1:plexin-A signaling in T cells could lead to similar actin depolymerization, causing the disassembly of molecular scaffolding supporting cellular polarization and the supramolecular activation complex at the immune synapse.
Nrp1
CD4Cre + mice may be susceptible to increased EAE severity because the lack of Nrp1 impairs suppression of autoreactive cells by the immune system, indirectly leading to increased autoinflammatory cell proliferation. Such a hypothesis is supported by previous findings that Nrp1 is constitutively expressed on T reg cells (14) . Indeed, we found that suppressor cells from Nrp1 flx/flx CD4Cre + mice have an impaired ability to suppress effector cells both in vitro and in vivo. Moreover, we found that WT CD4 + T cells sorted specifically for Nrp1 expression were as capable of or more effective at suppressing target cells than suppressors sorted specifically as CD4 + CD25 + , indicating that Nrp1 plays an important role in immune suppression.
Our result is consistent with findings that show that Nrp1 expression allows T reg cells to supplant effector T cells for the limited space available on primed APCs (22) . Along with our data showing that antigen and APCs are required for successful T reg cell function (as opposed to contact independent PMA/ionomycin stimulation), this result supports the notion of antigen-dependent regulatory T-cell suppression. As described by Sarris et al. (22) , Nrp1 greatly contributes to the fidelity of the immune synapse, thus favoring APC interactions with T cells that express Nrp1.
Alternatively, Nrp1 may function at the level of T reg cell stimulation. Several reports have shown that Nrp1 is important for T reg cell development (23, 24) , and Nrp1 has been proposed as a receptor for TGF-β (25) . Whether this interaction actually contributes to signaling, the functional activity of T reg cells is enhanced by Nrp1:TGF-β ligation. Because of the shared requirement of TGF-β for both T reg and T H -17 cells (26, 27) , Nrp1 may function to sequester TGF-β, simultaneously preventing the development of inflammatory T H -17 cells and promoting the differentiation of peripheral T reg cells. Consistent with this idea, neutralization of TGF-β inhibits Nrp1 suppressor capacity, whereas blockade of IL-10 had little or no impact.
In addition to naturally occurring T reg (nT reg ) cells, additional T reg subtypes emerge from the thymus as CD4 + CD25 − Foxp3 − cells. Although appearing phenotypically similar to a naïve CD4 + T cell, these inducible T reg (iT reg ) cells can be induced to express Foxp3 and CD25 in the periphery (28) . Such a notion of T reg cell heterogeneity is consistent with our results. We demonstrate that EAE-tolerant CD4 + cells from MOG ECi mice, with highly up-regulated Nrp1 levels, have only modestly up-regulated Foxp3 levels. Moreover, Nrp1 flx/flx CD4Cre + mice display virtually no variation in the Foxp3 + cell population. Despite this lack of fluctuation in Foxp3 expression, Nrp1-deficient suppressor T cells still have an impaired ability to attenuate immune proliferation. These results suggest that Nrp1 may simply be a mechanism used by cells capable of immune suppression and not specific to any regulatory cell lineage in particular. A cell capable of immune suppression would alter Nrp1 expression depending on inflammatory cues. As a result, any suppressive cell incapable of expressing Nrp1, whether a Foxp3 + nT reg cell or a type of iT reg cell, would have an impaired ability to curb autoinflammation.
In summary, we demonstrate that Nrp1 plays a critical role in the pathogenesis of EAE. Mice that lack Nrp1-expressing CD4 + T cells exhibit increased degenerative signs and CNS infiltration associated with EAE, preferential T H -17 cell commitment, enhanced proliferation and cytokine production, and impaired suppressor capacity. Our study provides evidence for a direct role of Nrp1 in an immune-mediated disease. This phenomenon is the combined result of increased inflammatory lineage commitment and impaired regulatory T-cell function. This study supports previous findings that Nrp1 may be essential for proper immune suppression. As the body of knowledge surrounding Nrp1 and T reg cell function expands, this molecule may prove to be a novel target for new treatments and therapies for diseases like MS.
Materials and Methods
Mice. Nrp1 conditional knockout mice were generated by crossing Nrp1 Epicutaneous Immunization, Retroviral Overexpression, ELISA, and RT-PCR. A description of the methods used for epicutaneous immunization, retroviral overexpression, ELISA, and RT-PCR can be found in SI Materials and Methods.
Statistics. P values are calculated by using the Student's t test.
